Education
About Us
Working with TipRanks
Follow Us
Willow Biosciences Inc (TSE:ATLE)
:ATLE
ATLE Stock Chart & Stats
C$0.16
--
Market closed
C$0.16
--
Day’s Range― - ―
52-Week RangeC$0.02 - C$0.40
Previous CloseN/A
VolumeN/A
Average Volume (3M)26.24K
Market Cap
C$55.65M
Enterprise Value-C$8.51M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.27
Next Earnings
Mar 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding352,222,660
10 Day Avg. Volume47,704
30 Day Avg. Volume26,236
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Willow Biosciences Inc News
ATLE FAQ
What was Willow Biosciences Inc’s price range in the past 12 months?
Willow Biosciences Inc lowest stock price was C$0.02 and its highest was C$0.40 in the past 12 months.
What is Willow Biosciences Inc’s market cap?
Willow Biosciences Inc’s market cap is C$55.65M.
When is Willow Biosciences Inc’s upcoming earnings report date?
Willow Biosciences Inc’s upcoming earnings report date is Mar 31, 2026 which is in 95 days.
How were Willow Biosciences Inc’s earnings last quarter?
Willow Biosciences Inc released its earnings results on Nov 14, 2025. The company reported -C$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.001.
Is Willow Biosciences Inc overvalued?
According to Wall Street analysts Willow Biosciences Inc’s price is currently Overvalued.
Does Willow Biosciences Inc pay dividends?
Willow Biosciences Inc does not currently pay dividends.
What is Willow Biosciences Inc’s EPS estimate?
Willow Biosciences Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Willow Biosciences Inc have?
Willow Biosciences Inc has 352,222,660 shares outstanding.
What happened to Willow Biosciences Inc’s price movement after its last earnings report?
Willow Biosciences Inc reported an EPS of -C$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Willow Biosciences Inc?
Currently, no hedge funds are holding shares in TSE:ATLE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Willow Biosciences Inc
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. was incorporated in 1981 and is headquartered in Calgary, Canada.
Technical Analysis
iAnthus Capital Holdings
―
Quantum Biopharma
―
Decibel Cannabis Company
―
Vext Science
―
BioNxt Solutions
―
Options Prices
Currently, No data available
---